Clinician's Roundtable

Guest: Maria Hordinsky, MD, FAAD From clinical research to direct patient care, dermatology tools powered by artificial intelligence (AI) present a new approach to hair loss treatment. Dr. Maria Hordinsky explains how virtual tattoo technology and at-home devices now provide measurable data, improving patient outcomes and allowing dermatologists to personalize treatment with precision. Dr. Hordinsky is the R. W. Goltz Professor and Vice Chair of Research in the Department of Dermatology at the University of Minnesota, and she spoke about this topic at the 2025 American Academy of Dermatology National Meeting.

Guest: Maria Hordinsky, MD, FAAD Artificial intelligence (AI) is reshaping dermatology care, but integrating it into clinical practice comes with challenges. Dr. Maria Hordinsky explores how clinics must adapt workflows and invest in new technologies to fully harness the potential for AI to drive better hair loss treatment. Dr. Hordinsky is the R. W. Goltz Professor and Vice Chair of Research in the Department of Dermatology at the University of Minnesota.

Guest: Eva Parker, MD, FAAD Rising temperatures, worsening air quality, and extreme weather events appear to be increasing the prevalence and severity of skin diseases. Dr. Eva Parker, Assistant Professor of Dermatology and Core Faculty at the Center for Biomedical Ethics and Society at Vanderbilt University Medical Center, shares strategies for dermatologists to improve climate literacy, reduce their carbon footprint, and educate patients on protecting their skin against climate-related impacts.

Guest: Shari Lipner, MD A combination of clinical evaluation, histopathology, and emerging imaging techniques can help diagnose nail psoriasis. Hear from Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine, as she explains common characteristics of nail psoriasis and best practices for diagnosing it and distinguishing it from similar diseases.

Guest: Shari Lipner, MD Nail psoriasis requires a patient-centric approach that balances targeted treatments with realistic expectations. Dr. Shari Lipner shares expert insights on intralesional steroids, topical therapies, and advanced systemic options to manage this challenging condition. Dr. Lipner is an Associate Professor of Clinical Dermatology and the Director of the Nail Center at Weill Cornell Medicine.

Guest: Atul A. Deodhar, MD, MRCP Despite feeling some symptom relief with treatment, patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis often experience persistent unmet needs. Residual pain, fatigue, and uncertainty about whether current therapies alter disease progression and outcomes are a few of the challenges that remain unaddressed, emphasizing the need for improved understanding and management of these conditions. Learn about how these difficulties impact patients with Dr. Atul Deodhar, Professor of Medicine and Medical Director of Rheumatology Clinics at Oregon Health & Science University.

Host: Brian P. McDonough, MD, FAAFP Guest: Paul P. Doghramji, MD, FAAFP For patients with IBS-D, the stigma surrounding the condition can make it difficult to openly discuss their symptoms and accept their diagnosis. Providing reassurance and a clear path forward can help create a supportive and comfortable environment for these patients. To learn more about how we can destigmatize IBS-D, Dr. Brian McDonough sits down with Dr. Paul Doghramji, who’s the Medical Director of Health Services at Ursinus College and a physician at Collegeville Family Practice and Pottstown Memorial Medical Center. Salix Pharmaceuticals400 Somerset Corporate Blvd.Bridgewater, NJ 08807© 2025 Salix Pharmaceuticals or its affiliates. MED-US-NPR-0053

Host: Brian P. McDonough, MD, FAAFP Guest: Holly S. Greenwald, MD Misconceptions around irritable bowel syndrome with diarrhea (IBS-D) can contribute to significant gaps in care and unmet patient needs. Primary care providers play a crucial role in addressing these needs and ensuring an accurate diagnosis. To learn more about best practices for diagnosing and communicating with patients, Dr. Brian McDonough sits down with Dr. Holly Greenwald, Assistant Professor of Clinical Medicine at Temple University Lewis Katz School of Medicine. Salix Pharmaceuticals400 Somerset Corporate Blvd.Bridgewater, NJ 08807© 2025 Salix Pharmaceuticals or its affiliates. MED-US-NPR-0048

Guest: Robert Gniadecki, MD For patients with psoriasis, the most effective therapy is not always accessible. Considering patient-specific factors, including overall health, can help create a holistic treatment plan. Tune in to hear from Dr. Robert Gniadecki, Professor and Director of the Division of Dermatology at the University of Alberta, as he discusses best practices for tailoring psoriasis management.

Guest: Daniel M. Klufas, MD For patients with hidradenitis suppurativa, treatment varies by stage. Topicals, antibiotics, biologics, and procedural interventions can all play a role in management depending on symptoms and severity. Learn more as Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco discusses current options and best practices for optimal care.

Guest: Daniel M. Klufas, MD Early diagnosis and prompt intervention in hidradenitis suppurativa patients are essential to preventing long-term impacts. With emerging treatments on the horizon, the future of hidradenitis suppurativa care is promising. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, provides insight into the future of diagnosis and treatment.

Guest: Daniel M. Klufas, MD Hidradenitis suppurativa is a chronic skin condition characterized by painful abscesses, sinus tracts, and immune dysregulation. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, explains the symptoms, impacts, and unmet needs associated with the disease.

Host: Raj Chovatiya, MD, PhD In light of the Maui Derm 2025 conference, Dr. Raj Chovatiya is here to discuss the most significant updates in the dermatology field that helped define 2024. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Host: Raj Chovatiya, MD, PhD Here to share a glimpse into where the dermatology field might be headed based on updates from the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Host: Raj Chovatiya, MD, PhD Here to share his insights on the key themes and topics covered at the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Host: Raj Chovatiya, MD, PhD How should we approach caring for undifferentiated eczema patients who didn’t have eczema as a child, who doesn’t have atopic co-morbidities, and isn’t flexural? Here to give a quick overview of his session at the Maui Derm 2025 conference that sought to help answer this question is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.

Guest: Rasheed A. Gbadegesin, MD, MBBS A new study by the H3 Africa Kidney Research Network found that APOL1 variants are a major risk factor for chronic kidney disease. Additionally, these variants are particularly prevalent among West Africans. Dr. Rasheed Gbadegesin dives into these findings and explains how they could contribute to preventive measures and improved outcomes in patients of African ancestry. Dr. Gbadegesin is the Director of the Office of Physician-Scientist Development at Duke University School of Medicine.

Guest: Mohamed Ibrahim, MB, BCh IgA nephropathy (IgAN) is a rare autoimmune kidney disease in which IgA deposits damage kidney filters, causing symptoms like proteinuria and swelling. While symptoms can overlap with other kidney diseases, IgAN presents challenges of its own. Learn about the unique characteristics of IgAN with Dr. Mohamed Ibrahim, an Assistant Professor of Transplant Nephrology at the University of Maryland School of Medicine.

Guest: Jennifer Moore, MS, RDN, CSR, LDN Host: Charles Turck, PharmD, BCPS, BCCCP IgA nephropathy, or IgAN, is a rare kidney disease that requires dietary changes to maintain kidney health and function while supporting other organ systems. Learn about the most crucial dietary considerations for these patients from Jennifer Moore, a renal nutrition expert.

Host: Gates B. Colbert, MD Guest: Kelly Helm Over 35 million people in the United States suffer from some form of chronic kidney disease, but many of them lack the support and education to navigate their condition and receive the best possible care. After her daughter was diagnosed with a rare kidney disease, Kelly Helm discovered the many obstacles associated with management and treatment. Hear from Kelly as she sits down with Dr. Gates Colbert to share what she’s learned as a parent, caregiver, and advocate. Kelly is the Executive Director of Patient Engagement at NephCure, a nonprofit organization dedicated to supporting and empowering patients with rare kidney diseases.